Aura Biosciences shares are trading higher after HC Wainwright & Co. maintained a buy rating on the stock and raised its price target from $21 to $22.
Portfolio Pulse from Benzinga Newsdesk
Aura Biosciences shares rose following HC Wainwright & Co.'s decision to maintain a buy rating and increase the price target from $21 to $22.
October 18, 2024 | 1:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Aura Biosciences shares increased after HC Wainwright & Co. reaffirmed a buy rating and raised the price target from $21 to $22.
The increase in price target and maintained buy rating by a reputable firm like HC Wainwright & Co. is likely to boost investor confidence, leading to a positive short-term impact on Aura Biosciences' stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100